Impact of remote management of diabetes via computer: The 360 study - A proof-of-concept randomized trial

Diabetes Technology and Therapeutics

Volumn 15, Issue 5, 2013, Pages 434-438

  Leichter, Steven B ^a,d   Bowman, Kelly ^b   Adkins, Royce A ^b   Jelsovsky, Zhihong ^c  

^a Center for Diabetes and Metabolism   (United States)

^b Center for Diabetes and Metabolism   (United States)

^c Biostat International   (United States)

^d MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AMBULATORY CARE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPUTER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELECONSULTATION; TELEMEDICINE; TELEPHONE; TIME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; BODY WEIGHT; COMPUTERS; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TELEMEDICINE; TELEPHONE; UNITED STATES;

EID: 84877650627     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0323     Document Type: Article

References (174)

1. Gingrich N, Boxer R, Brooks B: Telephone medical consults answer the call for accessible, affordable, and convenient healthcare. Telemed J E Health 2008;14:215-223.
2. Stroetmann KA, Kubitschke F, Robinson S, Stroetmann V, Cullen K, McDaid D: How Can Telehealth Help in the Provision of Integrated Care? Policy Brief 13. 2010. Www.euro.who.int/-data/assets/pdf-file/0011/120998/E94265 .pdf (accessed August 15, 2012
3. Bellazzi R: Telemedicine and diabetes management: Current challenges and future research directions. J Diabetes Sci Technol 2008;2:98-104.
4. Baig A, Wilkes A, Davis A, Peak M, Huang E, Bell D, Chin M: The use of quality improvement and health information technology to improve diabetes outcomes in African- American and Hispanic patients. Med Care Res Rev 2010;67(5 SUPPL.):163S-197S.
5. Hjelm NM: Benefits and drawbacks of telemedicine. J Telemed Telecare 2005;11:60-70.
6. Ralston JD, Hirsch IB, Hoath J, Mullen M, Cheadle A, Goldberg HI: Web-based collaborative care for type 2 diabetes. Diabetes Care 2009;32:234-239.
7. Piette JD: Interactive behavior change technology to support diabetes self-management. Diabetes Care 2007;30:2425-2432.
8. Moreno L, Dale SB, Chen AY, Magee CA: Costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstration. Diabetes Care 2009;32:1202-1204.
9. Palmas W, Shea S, Staren J, Teresi JA, Ganz ML, Burton TM, Pashos CL, Bluestein J, Field L, Morin PC, Izquierdo RE, Silver S, Emlicke JP, Lantigua RA, Weinstock RS: Medicare payments, healthcare service use, and telemedicine implementation costs in a randomized trial comparing telemedicine case management with usual care in medically underserved participants with diabetes. (IDEATel). J Am Med Inform Assoc 2010;17:196-202.
10. Centers for Medicare and Medicaid Services: Overview: What's an ACÖ www.CMS.gov/ACO/ (accessed August 15, 2012
11. National Committee for Quality Assurance. ADA/NCQA Guidelines, ''2011 DM Measures.'' March 15, 2011. Www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/ HEDIS2011.aspx (accessed August 15, 2012
12. Aoki N, Dunn K, Fukui T, Beck JR, Schull WJ, Li HK: Costeffectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care 2004;27: 1095-1101.
13. World Medical Association: Declaration of Helsinki: Ethical principles for medical research involving human subjects. www.Wma.Net/en/30publications/ 10policies/b3/index .html (accessed August 15, 2012
14. Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK: Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003; 26:1475-1479.
15. Izquierdo R, Knudson PE, Meyer S, Kearns J, Ploutz-Snyder R, Weinstock RS: A comparison of diabetes education administered through telemedicine versus in person. Diabetes Care 2003;26:1002-1007.
16. Klonoff DC: Diabetes and telemedicine. Diabetes Care 2003; 26:1626-1628.
17. Davis RM, Hitch AD, Salaam MM, Herman WH, Zimmer- Caller IE, Mayer-Davis EJ: TeleHealth improves diabetes self-management in an underserved community: Diabetes TeleCare. Diabetes Care 2010;33:1712-1717.
18. Larsen ME, Turner J, Farmer A, Neil A, Tarassenko L: Telemedicine supported insulin optimisation in primary care. J Telemed Telecare 2010;16:433-440.
19. Smith SA, Shah ND, Bryant SC, Christianson TJH, Giesler PD, Krause K, Erwin PJ, Montori VM: Chronic care model and shared care in diabetes: Random trial of electronic decision support system. Mayo Clin Proc 2008;83:747-757.
20. Wood D: The move to accountable care organizations involves telemedicine. Telemed J E Health 2011;17:237-240.
21. Agarwal S, Lau C: Remote health monitoring using mobile phones and Web services. Telemed J E Health 2010;16: 603-607.
22. Istepanian RSH, Zitouni K, Harry D, Moutosammy N, Sungoor A, Tang B, Earle K: Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes. J Telemed Telecare 2009;15:125-128.
23. Nemours Children's Clinic, Jacksonville, FL: Nelly Mauras, MD (PI), Larry A. Fox, MD (I), Kim Englert, RN (C), Joe Permuy, ARNP (C), and Kaitlin Sikes (C
24. Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, CA: Bruce A. Buckingham, MD (PI), Darrell M. Wilson, MD (I), Paula Clinton, RD, CDE (C), and Kimberly Caswell, APRN (C). 4. Department of Pediatrics, Yale University School of Medicine, New Haven, CT: Stuart A. Weinzimer, MD (PI), William V. Tamborlane, MD (I), Jennifer Sherr, MD (I), Amy Steffen, BS (C), Kate Weyman, MSN (C), Melinda Zgorski, BSN (C), and Eileen Tichy, MMS (C
25. Washington University in St. Louis, St. Louis, MO: Neil H. White, MD (PI), Ana Maria Arbelaez, MD (I), Lucy Levandoski, PA-C (C), and Angie Starnes, RN, BSN, CDE (C Gale EA, Tattersall RB: Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979;1:1049-1052.
26. Jauch-Chara K, Schultes B: Sleep and the response to hypoglycaemia. Best Pract Res Clin Endocrinol Metab 2010; 24:801-815.
27. Pickup JC, Freeman SC, Sutton AJ: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Metaanalysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805.
28. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
29. Bay C, Kristensen PL, Pedersen-Bjergaard U, Tarnow L, Thorsteinsson B: Accuracy of nocturnal Continuous Glucose Monitoring System (CGMS) in patients with type 1 diabetes at high risk of severe hypoglycaemia [abstract]. Diabetologia 2012;55(SUPPL. 1):S255.
30. Kristensen PL, Pedersen-Bjergaard U, Beck-Nielsen H, Norgaard K, Perrild H, Christiansen JS, Jensen T, Parving HH, Thorsteinsson B, Tarnow L: A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): Study rationale and design. BMC Endocr Disord 2012;12:10.
31. Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, Nørgaard K, Perrild H, Parving HH, Thorsteinsson B, Tarnow L: Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract 2012;96:17-23.
32. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B: Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003;19:232-240.
33. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: The Guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113.
34. UK Hypoglycaemia Study Group: Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration. Diabetologia 2007;50:1140-1147.
35. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL: Evaluating the accuracy of continuous glucose-monitoring sensors: Continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004;27:1922-1928.
36. Clarke WL: The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther 2005;7:776-779.
37. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C: Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. BMJ 1985;291:376-379.
38. Bendtson I, KvernelandA, Pramming S, Binder C: Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy. ActaMed Scand 1988;223:543-548.
39. Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH: Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: Frequency, duration and associations. Diabet Med 2007;24: 527-532.
40. Davey RJ, Stevens K, Jones TW, Fournier PA: The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. Prim Care Diabetes 2012;6:35-39.
41. Mastrototaro J, Shin J, Marcus A, Sulur G: The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther 2008;10:385-390.
42. Zijlstra E, Heise T, Nosek L, Heinemann L, Heckermann S: Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab 2012;53:112-117.
43. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the Mini- Med continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56.
44. Peoples T, Bailey T, Ronald B, Zisser HC, Janowski B, Huang S, Talbot C, Yang Q: Accuracy performance of the Medtronic NexSensor for 6 days in an inpatient setting using abdomen and buttocks insertion sites. J Diabetes Sci Technol 2011; 5:358-364.
45. Lee S, Bailey T, Brazg R, Christiansen M, Ahmann A, Henry R, Garg S, Watkins E, Kaufman F: Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor [abstract]. Diabetologia 2012;55(SUPPL. 1):S428.
46. Keenan DB, Mastrototaro JJ, Zisser H, Cooper KA, Raghavendhar G, Lee SW, Yusi J, Bailey TS, Brazg RL, Shah RV: Accuracy of the Enlite 6-day glucose sensor with Guardian and Veo calibration algorithms. Diabetes Technol Ther 2012;14:225-231.
47. Simpson P, Peyser T, Price D, Garcia A, Nakamura K: Impact of study design and analytic techniques on reported accuracy of continuous glucose monitoring (CGM) systems. Diabetologia 2012;55(SUPPL. 1):S431-S432.
48. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE: Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004;6:339- 347.
49. Keenan DB, Cartaya R, Mastrototaro JJ: Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol 2010;4:111-118.
50. Jones JM, Lawson ML, Daneman D, Olmsted MP, Rodin G: Eating disorders in adolescent females with and without type 1 diabetes: Cross sectional study. BMJ 2000;320:1563- 1566.
51. Colton P, Olmsted M, Daneman D, Rydall A, Rodin G: Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: A casecontrolled study. Diabetes Care 2004;27:1654-1659.
52. Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K: Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care 2008;31:415-419.
53. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF: Insulin omission in women with IDDM. Diabetes Care 1994;17:1178-1185.
54. Paris CA, Imperatore G, Klingensmith G, Petitti D, Rodriguez B, Anderson AM, Schwartz ID, Standiford DA, Pihoker C: Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: The SEARCH for Diabetes in Youth study. J Pediatr 2009;155:183-189.
55. Battaglia MR, Alemzadeh R, Katte H, Hall PL, Perlmuter LC: Brief report: Disordered eating and psychosocial factors in adolescent females with type 1 diabetes mellitus. J Pediatr Psychol 2006;31:552-556.
56. Pinhas-Hamiel O, Graph-Barel C, Boyko V, TzadokM, Lerner- Geva L, Reichman B: Long-term insulin pump treatment in girls with type 1 diabetes and eating disorders - is it feasible? Diabetes Technol Ther 2010;12:873-878.
57. Young-Hyman DL, Davis CL: Disordered eating behavior in individuals with diabetes: Importance of context, evaluation, and classification. Diabetes Care 2010;33:683-689.
58. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC Growth Charts for the United States: Methods and development. Vital Health Stat 11 2002;(246):1-190.
59. Markowitz JT, Butler DA, Volkening LK, Antisdel JE, Anderson BJ, Laffel LM: Brief screening tool for disordered eating in diabetes: Internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes. Diabetes Care 2010;33:495-500.
60. Markowitz JT, Lowe MR, Volkening LK, Laffel LM: Selfreported history of overweight and its relationship to disordered eating in adolescent girls with type 1 diabetes. Diabet Med 2009;26:1165-1171.
61. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142- 1146.
62. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH: Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: A systematic review and meta-analysis. Ann Intern Med 2012; 157:336-347.
63. Diabetes Research in Children Network (DirecNet) Study Group: Performance of the DCA2000 for measurement of HbA1c levels in children with T1DM in a DirecNet outpatient clinical trial. Pediatr Diabetes 2005;6:13-16. Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of Obesity in the United States, 2009-2010. NCHS Data Brief, No. 82. Hyattsville, MD: National Center for Health Statistics, 2012.
64. Total National Health Expenditures: Centers for Medicare & Medicaid Services, Office of the Actuary: Data from the National Statistics Group, October 2010.
65. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-1757.
66. International Diabetes Federation: Diabetes Atlas, 5th ed. 2011. www.idf.org/sites/default/files/NAC-5E-Update- Country.pdf (accessed January 2013
67. Garg SK, Moser E: How basal insulin analogs have changed diabetes care. Diabetes Technol Ther 2011;13(SUPPL.):S-1-S-4.
68. Garg SK, DiDomenico D, Switzer S: Ways to reduce cardiovascular disease in diabetes. Diabetes Technol Ther 2012;14(SUPPL. 1):S-1-S-2.
69. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
70. Seidell JC, Bjorntorp P, Sjostrom L, Sannerstedt R, Krotkiewski M, Kvist H: Regional distribution of muscle and fat mass in men - new insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989;13:289-303.
71. Sidney S, Lewis CE, Hill JO, Quesenberry CP Jr, Stamm ER, Scherzinger A, Tolan K, Ettinger B: Association of total and central adiposity measures with fasting insulin in a biracial population of young adults with normal glucose tolerance: The CARDIA study. Obes Res 1999;7:265-272.
72. Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Giglio MD, Di Francesco V, Barillari M, Mucelli RP, Zamboni M: Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring) 2011;19:1747-1754.
73. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS: Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a communitybased sample: The Framingham Heart Study. Circulation 2008;117:605-613.
74. Donohoe CL, Doyle SL, Reynolds JV: Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 2011;3:12.
75. American College of Radiology: ACR Appropriateness Criteria. Radiation Dose Assessment Introduction. www.acr .org (accessed January 16, 2013
76. University of Colorado Department of Radiology: Radiation Dose Smart Card. 2012. www.ucdenver.edu/academics/ colleges/medicalschool/departments/ Radiology/Pages/ Radiology.aspx (accessed January 21, 2013
77. Saini S, Seltzer SE, Bramson RT, Levine LA, Kelley P, Jordan PF Chiango BF, Thrall JH: Technical cost of radiologic examinations: Analysis across imaging modalities. Radiology 2000;216:269-272.
78. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE: Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-177.
79. Amati F, Pennant M, Azuma K, Dubé JJ, Toledo FGS, Rossi AP, Kelley DE, Goodpaster BH: Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 2012;20:1115-1117.
80. Limanond P, Raman SS, Lassman C, Sayer J, Ghobrial RM, Busuttil RW, Saab S, Lu DS: Macrovesicular hepatic steatosis in living related liver donors: Correlation between CT and histologic findings. Radiology 2004;230:276-280.
81. Seidell, JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution - a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr 1990;51:953-957.
82. Klopfenstein BJ, Kim MS, Krisky CM, Szumowski J, Rooney WD, Purnell JQ: Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol 2012;85:e826-e830.
83. Dixon WT: Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
84. Ma J, Singh SK, Kumar AJ, Leeds NE, Broemeling LD: Method for efficient fast spin echo Dixon imaging. Magn Reson Med 2002;48:1021-1027.
85. Liu C-Y, McKenzie CA, Yu H, Brittain JH, Reeder SB: Fat quantification with IDEAL gradient echo imaging: Correction of bias from T1 and noise. Magn Reson Med 2007; 58:354-364.
86. Reeder SB, Cruite I, Hamilton G, Sirlin CB: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34: 729-749.
87. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT: Measurement of intracellular triglyceride stores by 1H spectroscopy: Validation in vivo. Am J Physiol 1999;276:E977-E989.
88. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS: Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009;94:4070-4076.
89. Kang B-K, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee M-G: Hepatic fat quantification: A prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012; 47:368-375.
90. Bohte AE, van Werven JR, Bipat S, Stoker J: The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: A meta-analysis. Eur Radiol 2011;21:87-97.
91. Maligie M, Crume T, Scherzinger A, Stamm E, Dabelea D: Adiposity, fat patterning, and the metabolic syndrome among diverse youth: The EPOCH study. J Pediatr 2012; 161:875-880.
92. Pickhardt PJ, Lee Y, O'Connor SD, Mun? oz del Rio A: Visceral adiposity and hepatic steatosis at abdominal CT: Association with the metabolic syndrome AJR 2012;198: 1100-1107.
93. Dulloo AG, Jacquet J, Solinas G, Montani J-P, Schutz Y: Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond) 2010;34(SUPPL. 2):S4- S17.
94. Maskarinec G, Grandinetti A, Matsuura G, Sharma S, Mau M, Henderson BE, Kolonel LN: Diabetes prevalence and body mass index differ by ethnicity: The Multiethnic Cohort. Ethn Dis 2009;19:49-55.
95. Nazare J, Smith JD, Borel A, Haffner SM, Balkau B, Ross R, Massien C, Almeras N, Despres JP: Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra- Abdominal Adiposity. Am J Clin Nutr 2012;96:714-726.
96. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR: Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509-1517.
97. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M: High incidence of metabolically active brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity. Diabetes 2009;58:1526-1531.
98. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D, Carpentier AC: Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012;122:545-552.
99. Ouellet V, Routhier-Labadie A, Bellemare W, Lakhal-Chaieb L, Turcotte E, Carpentier AC, Richard D: Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 2011;96:192-199.
100. Rothwell NJ, Stock MJ: Luxuskonsumption, diet-induced thermogenesis and brown fat: The case in favour. Clin Sci (Lond) 1983;64:19-23.
101. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J: UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 2009;9:203-209.
102. Khalili K, Lan FP, Hanbidge AE: Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 2003;180: 1601-1604.
103. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F: Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433-445.
104. Friedrich-Rust M, Ong MF, Martens S Sarazzin C, Bojunga J, Zeuzem S, Hermmann E: Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008;134:960-974.
105. Yoneda M, Suzuki K, Kato S, Fujita K, Nozaki Y, Hosono K, Saito S, Nlakajima A: Nonalcoholic fatty liver disease: USbased acoustic radiation force impulse elastography. Radiology 2010;256:640-647.
106. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL: Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259:749-756.
107. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY: Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 2006; 239:105-112.
108. Joe E, Lee JM, Kim KW, Lee KB, Kim SJ, Baek JH, Shin C Suh KS, Yi NJ, Han JK, Choi BI: Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2.-corrected chemical shift MRI. J Magn Reson Imaging 2012;36:1124-1130.
109. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ: Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008;28:937-945.
110. Chandler RC, Srinivas G, Chintapalli KN, Schwesinger WH, Prasad SR: Imaging in bariatric surgery: A guide to postsurgical anatomy and common complications. AJR Am J Roentgenol 2008;190:122-135.
111. Wu TM, Yang P, Huang YL, Chen JS, Chuo CC, Yeh C, Chang RS: Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: Concordance study with dedicated cardiac CT. AJR Am J Roentgenol 2008;190: 923-928.
112. Jacobs PCA, Isgum I, Gondrie MJA, Mali WPTM, Ginneken B, Prokop M, Graaf Y: Coronary artery calcification scoring in low-dose ungated CT screening for lung cancer: Interscan agreement. AJR Am J Roentgenol 2010;194:1244-1249.
113. Moscariello A, Vliegenthart R, Schoepf UJ, Nance JW, Zwerner PL, Meyer M, Townsend JC, Fernandes V, Sieinber DH, Fink C, Oudkerk M, Bonoma L, O'Brien TX, Henzler T: Coronary CT angiography versus conventional cardiac angiography for therapeutic decision making in patients with high likelihood of coronary artery disease. Radiology 2012;265:385-392.
114. Boudina S, Abel ED: Diabetic cardiomyopathy revisited. Circulation 2007;115:3213-3223.
115. Ernande L, Rietzschel ER, Bergerot C, Wen H: Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: A speckle-tracking imaging study. J Am Soc Echocardiogr 2010;23:1266-1272.
116. Ernande L, Thibault H, Bergerot C, Moulin P, Wen H, Derumeaux G, Croisille P: Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: Identification at MR imaging with cine displacement encoding with stimulated echoes. Radiology 2012;265:402-409.
117. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollack M, Regensteiner JG, Yee D: Diabetes and cancer. A consensus report. Diabetes Care 2010;33:1674-1685.
118. Pickhardt PJ, Hassan C, Laqhi A, Zullo A, Kim DH, Iafrate F, Morini S: Small and diminutive polyps detected at screening CT colonography: A decision analysis for referral to colonoscopy. AJR Am J Roentgenol 2002;190:136-144.
119. Austin JA, Garg K, Aberle D, Yankelevitz D, Kuriyama K, Lee HJ, Brambilla E, Travis WD: Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology 2013;266:62-71.
120. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguch M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson B: Evolving concepts in the pathol- ogy and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-3287.
121. Lee HY, Li Z, Chen K, Hsu AR, Xu C, Sun S, Chen X: PET/ MRI dual-modality tumor imaging using arginine-glycineaspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 2008;49:1371-1379.
122. Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X: PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterial 2010;31:3016-3022.
123. Krokowski M: Progressive theory of carcinogenesis suggesting that frequency of metastatic dissemination is related to tumor size. In: Kaiser WA, ed. MR-Mammography. Berlin: Springer-Verlag, 1993:3-22.
124. Ouwerkerk R, Pettigrew RI, Gharib AM: Liver metabolite concentrations measured with 1H MR spectroscopy. Radiology 2012;265:565-575.
125. Antkowiak PF, Vandsburger MH, Epstein FH: Quantitative pancreatic beta cell MRI using manganese-enhanced Look- Locker imaging and two-site water exchange analysis. Magn Reson Med 2012;67:1730-1739.
126. Marc D, Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K, Skovronsky DM, Herold KC, McCarthy TJ, Calle RA, Carson RE, Treadway JL, Cline GW: In vivo imaging of endogenous pancreatic b-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyldihydrotetrabenazine and PET. J Nucl Med 2012;53:908-916.
127. Labbé, SM, Grenier-Larouche T, Noll C, Phoenix S, Gue'rin B, Turcotte EE, Carpentier AA: Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucoseintolerant humans. Diabetes 2012;61:2701-2710.
128. Garg K, Samuel C, Ann S: Obesity and diabetes: Newer concepts in imaging. Diabetes Technol Ther 2013;15:351-361.
129. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS: Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009;84:84-91.
130. Mohan V, Shanthi Rani CS, Amutha A, Sravan D, Anjana RM, Parthasarathy B, Unnikrishnan R: Clinical profile of long term survivors (over 40 years duration) and non survivors with type 2 diabetes. Diabetes Care 2013; doi: 10.2337/dc12-1193.
131. Zhang PH, Chen ZW, Lv D, Xu YY, Gu WL, Zhang XH, Le YL, Zhu HH, Zhu YM: Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China. BMC Public Health 2012;12:567.
132. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla SK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V; the ICMR- INDIAB Collaborative Study Group: Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027.
133. Mazze RS, Lucido D, Langer O, Hartmann K, Rodbard D: Ambulatory glucose profile: Representation of verified selfmonitored blood glucose data. Diabetes Care 1987;10:111-117.
134. Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R: Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 2008;10:149-159.
135. Kowalski AJ, Dutta S: It's time to move from the A1c to better metrics for diabetes control. Diabetes Technol Ther 2013;15:194-196.
136. Kaufman FR: It's time for a standard glucose report from CGM. Diabetes Technol Ther 2013;15:197.
137. Garg SK: Standardization of self-monitoring of blood glucose and continuous glucose monitoring reporting. Diabetes Technol Ther 2013;15:193.
138. Serrano K: Regarding recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: The ambulatory glucose profile (AGP). Diabetes Technol Ther 2013;15:348.
139. Wiklund ME, Kendler J, Strochlic AY: Usability Testing of Medical Devices. Boca Raton, FL: CRC Press, 2010.
140. Wiklund ME, Wilcox SB: Designing Usability into Medical Products. Boca Raton, FL: CRC Press, 2005.
141. Fonda SJ, Paulsen CA, Perkins J, Kedziora RJ, Rodbard D, Bursell SE: Usability test of an internet-based informatics tool for diabetes care providers: The comprehensive diabetes management program. Diabetes Technol Ther 2008;10:16-24.
142. Rodbard D: Display of glucose distributions by date, time of day, and day of week: N 11. Rodbard D: Potential role of computers in clinical investigation and management of diabetes mellitus. Diabetes Care 1988;11(SUPPL. 1):54-61.ew and improved methods. J Diabetes Sci Technol 2009;3:1388-1394.
143. Rodbard D: New approaches to display of self-monitoring of blood glucose data. J Diabetes Sci Technol 2009;3:1121-1127.
144. Pernick N, Rodbard D: Personal computer programs to assist with home monitoring of blood glucose and self adjustment of insulin dosage. Diabetes Care 1986;9:61-69.
145. Rodbard D: Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol 2007;1:62-71.
146. Welsh JB, Kannard B, Nogueira K, Kaufman FR, Shah R: Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: The CareLink- database. Pediatr Endocrinol Rev 2010;7(SUPPL. 3):413-416.
147. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young- HymanD, Schlundt D, ClarkeW: Assessment of risk for severe hypoglycemia among adults with IDDM: Validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875.
148. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009; 11(SUPPL. 1):S-45-S-54.
149. Rodbard D: Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(SUPPL. 1):S-55-S-57.
150. Rodbard D: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009;11:551-565.
151. Rodbard D: Improved methods for calculating a ''figure of merit'' for blood glucose monitoring data [abstract]. J Diabetes Sci Technol 2007;1:438.
152. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758.
153. Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR: Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011;13:921-928.
154. Rodbard D: Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution. Diabetes Technol Ther 2012;14:868-876.
155. Rodbard D: A semi-logarithmic scale for glucose provides a balanced view of hyper- and hypoglycemia. J Diabetes Sci Technol 2009;3:1395-1401.
156. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg S: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11:717-723.
157. Rodbard D, Jovanovic L, Garg S: Impact of continuous glucose monitoring on glycemic variability and glucose control in subjects with type 1 diabetes using multiple daily injections versus insulin pump. Diabetes Technol Ther 2009;11:757-765.
158. Snell-Bergeon JK, Rodbard D, Roman R, Garg S, Maahs D, Schauer I, Bergman B, Kinney GL, Rewers M: Glycaemic variability and coronary artery calcium: The Coronary Artery Calcification in Type 1 Diabetes Study. Diabet Med 2010; 27:1436-1442.
159. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR: Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 2003;26:1-8.
160. Hill NR: Computer program for calculating several of the parameters of glycemic variability. http://www.easygv .co.uk/ (accessed April 23, 2013
161. Rodbard D: Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med 2011;123:107-118.
162. Rodbard D: Glycemic variability: Measurement and utility in clinical medicine and research - one viewpoint. Diabetes Technol Ther 2011;13:1077-1080.
163. Rodbard D: The challenges of measuring glycemic variability. J Diabetes Sci Technol 2012;6:712-715.
164. Thomas A, Schönauer M, Achermann F, Schnell O, Hanefeld M, Ziegelasch HJ, Mastrototaro J, Heinemann L: The ''glucose pentagon'': Assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther 2009;11: 399-409.
165. Cameron FJ, Baghurst PA, Rodbard D: Assessing glycaemic variation: why, how and when? Pediatr Endocrinol Rev 2010;7(SUPPL. 3):432-444.
166. Braithwaite SS: Glycemic variability in hospitalized patients: Choosing metrics while awaiting the evidence. Curr Diab Rep 2013;13:138-154.
167. Baghurst PA: Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: An automated algorithm. Diabetes Technol Ther 2011;13:296-302.
168. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W: GlyCulator: A glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol 2011;5:447-451.
169. Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E: The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 2011;13:319-325.
170. Marling CR, Shubrook JH, Vernier SJ, Wiley MT, Schwartz FL: Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol 2011;5:871-884.
171. Rawlings RA, Shi H, Yuan LH, Brehm W, Pop-Busui R, Nelson PW: Translating glucose variability metrics into the clinic via continuous glucose monitoring: A Graphical User Interface for Diabetes Evaluation (CGM-GUIDEa). Diabetes Technol Ther 2011;13:1241-1248.
172. Rodbard D, Vigersky RA: Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus. J Diabetes Sci Technol 2011;5:402- 411; online appendix
173. Rodbard HW, Schnell O, Unger J, Rees C, Amstutz L, Parkin CG, Jelsovsky Z, Wegmann N, Axel-Schweitzer M, Wagner RS: Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care 2012;35:693-698.
174. O'Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, Asche SE, Ekstrom HL, Gilmer TP: Impact of electronic health record clinical decision support on diabetes care: A randomized trial. Ann Fam Med 2011;9:12-21.